Addus HomeCare (ADUS) Financials

$110.45 -2.06 (-1.83%)

As of 01:34 PM Eastern

Annual Income Statements for Addus HomeCare

This table shows Addus HomeCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Income / (Loss) Attributable to Common Shareholders	74	63	46	45	33	25	16	12	12	12	12
Consolidated Net Income / (Loss)	74	63	46	45	33	25	16	12	12	12	12
Net Income / (Loss) Continuing Operations	74	63	46	45	33	26	16	12	12	11	12
Total Pre-Tax Income	99	81	60	60	42	33	20	21	16	15	17
Total Operating Income	103	91	69	66	45	35	23	25	15	16	18
Total Gross Profit	375	340	300	270	226	179	137	116	99	87	84
Total Revenue	1,155	1,059	951	864	765	649	517	426	401	337	313
Operating Revenue	1,155	1,059	951	864	765	649	517	426	401	337	313
Total Cost of Revenue	780	719	651	595	539	470	380	310	302	250	229
Operating Cost of Revenue	780	719	651	595	539	470	380	310	295	245	229
Total Operating Expenses	272	249	231	204	182	144	114	91	83	71	66
Selling, General & Admin Expense	259	235	217	189	170	134	105	77	77	66	62
Depreciation Expense	14	14	14	14	12	11	8.64	6.66	6.65	4.72	3.83
Total Other Income / (Expense), net	-3.34	-9.63	-8.57	-5.54	-2.57	-1.58	-2.42	-4.19	0.69	-0.74	-0.68
Interest Expense	7.73	11	8.91	5.81	3.19	3.11	5.02	4.47	2.33	0.79	0.70
Interest & Investment Income	4.39	1.48	0.34	0.27	0.62	1.52	2.59	0.07	2.81	0.05	0.02
Income Tax Expense	26	19	14	15	8.81	7.36	4.10	9.26	4.10	3.93	5.43
Basic Earnings per Share	$4.33	$3.91	$2.90	$2.87	$2.12	$1.83	$1.36	$1.04	$1.07	$1.06	$1.12
Weighted Average Basic Shares Outstanding	17.01M	16.00M	15.86M	15.74M	15.60M	13.82M	12.05M	11.47M	11.29M	10.99M	10.90M
Diluted Earnings per Share	$4.23	$3.83	$2.84	$2.81	$2.08	$1.77	$1.33	$1.03	$1.07	$1.04	$1.10
Weighted Average Diluted Shares Outstanding	17.38M	16.31M	16.18M	16.06M	15.96M	14.25M	12.38M	11.62M	11.35M	11.19M	11.11M
Weighted Average Basic & Diluted Shares Outstanding	18.17M	16.23M	16.13M	15.95M	15.60M	13.82M	12.10M	11.50M	11.30M	11M	10.90M

This table shows Addus HomeCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	21	20	20	18	16	20	15	15	13	15	12
Consolidated Net Income / (Loss)	21	20	20	18	16	20	15	15	13	15	12
Net Income / (Loss) Continuing Operations	21	20	20	18	16	20	15	15	13	15	12
Total Pre-Tax Income	27	26	27	25	21	25	20	19	16	18	15
Total Operating Income	31	27	26	26	24	28	23	22	19	21	18
Total Gross Profit	108	101	92	93	88	92	87	82	78	79	75
Total Revenue	338	297	290	287	281	276	271	260	252	247	240
Operating Revenue	338	297	290	287	281	276	271	260	252	247	240
Total Cost of Revenue	230	196	198	194	193	184	184	178	173	168	165
Operating Cost of Revenue	230	196	198	194	193	184	184	178	173	168	165
Total Operating Expenses	77	75	66	67	65	64	64	61	60	58	58
Selling, General & Admin Expense	73	71	63	64	61	61	60	57	56	54	54
Depreciation Expense	3.94	3.21	3.45	3.40	3.47	3.68	3.62	3.38	3.45	3.49	3.44
Total Other Income / (Expense), net	-3.52	-0.70	1.34	-1.64	-2.34	-2.62	-2.62	-2.04	-2.36	-2.54	-2.39
Interest Expense	4.02	2.29	0.57	2.11	2.76	3.12	3.20	2.33	2.46	2.63	2.47
Interest & Investment Income	0.50	1.59	1.91	0.47	0.42	0.50	0.58	0.29	0.11	0.09	0.08
Income Tax Expense	5.77	6.69	7.13	6.46	5.48	5.78	4.81	4.65	3.58	3.52	3.58
Basic Earnings per Share	$1.18	$1.09	$1.13	$1.12	$0.99	$1.23	$0.96	$0.93	$0.79	$0.92	$0.73
Weighted Average Basic Shares Outstanding	17.98M	17.01M	17.87M	16.18M	16.06M	16.00M	16.01M	16.00M	15.95M	15.86M	15.87M
Diluted Earnings per Share	$1.16	$1.06	$1.10	$1.10	$0.97	$1.19	$0.95	$0.91	$0.78	$0.90	$0.71
Weighted Average Diluted Shares Outstanding	18.31M	17.38M	18.26M	16.50M	16.37M	16.31M	16.29M	16.28M	16.30M	16.18M	16.18M
Weighted Average Basic & Diluted Shares Outstanding	18.40M	18.17M	18.13M	18.10M	16.37M	16.23M	16.21M	16.21M	16.20M	16.13M	16.11M

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Net Change in Cash & Equivalents	34	-15	-89	24	33	41	17	46	3.91	-9.26	-2.20
Net Cash From Operating Activities	116	112	105	39	109	12	33	53	-0.74	4.11	7.03
Net Cash From Continuing Operating Activities	116	112	105	39	109	12	33	53	-0.74	4.11	7.03
Net Income / (Loss) Continuing Operations	74	63	46	45	33	25	16	12	12	12	12
Consolidated Net Income / (Loss)	74	63	46	45	33	25	16	12	12	12	12
Depreciation Expense	14	14	14	14	12	11	8.64	6.66	6.65	4.72	3.83
Amortization Expense	1.05	0.86	0.86	0.80	0.74	0.72	0.61	1.87	0.36	0.10	0.15
Non-Cash Adjustments To Reconcile Net Income	19	3.46	21	-18	28	6.11	4.42	9.99	11	6.01	3.65
Changes in Operating Assets and Liabilities, net	9.22	31	23	-3.42	36	-31	3.10	22	-31	-18	-13
Net Cash From Investing Activities	-355	-119	-107	-42	-214	-189	-68	-24	-22	-11	-12
Net Cash From Continuing Investing Activities	-355	-119	-107	-42	-214	-189	-68	-24	-22	-11	-12
Purchase of Property, Plant & Equipment	-6.05	-9.45	-8.30	-4.65	-6.83	-4.62	-5.35	-3.62	-1.71	-2.21	-5.27
Acquisitions	-354	-110	-98	-37	-208	-184	-62	-24	-20	-8.51	-7.22
Sale of Property, Plant & Equipment	0.03	0.02	0.00	0.00	-	-	-	3.70	-	-	-
Divestitures	5.36	0.00	0.00	0.00	0.26	0.00	0.00	-	-	-	-
Net Cash From Financing Activities	272	-8.18	-87	26	138	218	51	17	26	-2.64	3.27
Net Cash From Continuing Financing Activities	272	-8.18	-87	26	138	218	51	17	26	-2.64	3.27
Repayment of Debt	-140	-119	-137	-21	-0.74	-1.11	-106	-77	-30	-2.22	-0.66
Issuance of Debt	233	110	47	46	135	43	80	95	52	-	2.90
Issuance of Common Equity	176	0.00	0.00	0.00	0.00	173	77	0.00	-	-	-
Other Financing Activities, net	3.44	0.32	2.55	1.11	3.92	3.09	-0.02	-0.27	4.01	-0.43	1.03
Cash Interest Paid	6.52	10	7.99	5.09	2.37	2.32	4.34	2.26	2.32	0.79	0.70
Cash Income Taxes Paid	26	15	1.48	18	11	7.30	4.10	6.73	5.09	0.91	4.47

This table details how cash moves in and out of Addus HomeCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-1.96	-124	50	97	12	-15	-4.44	11	-6.42	-26	-15
Net Cash From Operating Activities	19	10	49	19	39	30	22	42	19	24	18
Net Cash From Continuing Operating Activities	19	10	49	19	39	30	22	42	19	24	18
Net Income / (Loss) Continuing Operations	21	20	20	18	16	20	15	15	13	15	12
Consolidated Net Income / (Loss)	21	20	20	18	16	20	15	15	13	15	12
Depreciation Expense	3.94	3.21	3.45	3.40	3.47	3.68	3.62	3.38	3.45	3.49	3.44
Amortization Expense	0.32	0.41	0.21	0.22	0.22	0.22	0.22	0.22	0.22	0.22	0.22
Non-Cash Adjustments To Reconcile Net Income	0.98	2.03	3.81	2.57	11	0.64	0.63	1.75	0.45	-5.37	7.37
Changes in Operating Assets and Liabilities, net	-7.52	-15	21	-5.46	8.54	5.94	1.91	21	2.02	11	-4.25
Net Cash From Investing Activities	-1.38	-354	-1.92	3.55	-1.75	-5.30	-111	-0.97	-1.74	-19	-1.33
Net Cash From Continuing Investing Activities	-1.38	-354	-1.92	3.55	-1.75	-5.30	-111	-0.97	-1.74	-19	-1.33
Purchase of Property, Plant & Equipment	-1.88	-1.70	-1.93	-1.07	-1.35	-5.32	-2.36	-0.99	-0.78	-5.44	-1.33
Acquisitions	-3.35	-354	-	-	-0.40	0.00	-109	0.03	-0.97	-14	-
Sale of Property, Plant & Equipment	0.01	-	0.01	-	-	0.02	-	-	-	-	-
Divestitures	3.85	0.76	-	-	-	-	-	-	-	-	-
Net Cash From Financing Activities	-20	220	2.94	74	-25	-40	85	-30	-23	-31	-32
Net Cash From Continuing Financing Activities	-20	220	2.94	74	-25	-40	85	-30	-23	-31	-32
Repayment of Debt	-20	-13	-0.04	-101	-25	-40	-25	-30	-24	-32	-45
Other Financing Activities, net	0.49	0.45	2.98	-	0.00	0.29	-	-	0.03	1.26	0.74
Cash Interest Paid	3.74	1.72	0.31	1.96	2.53	2.89	2.95	2.11	2.31	2.40	2.19
Cash Income Taxes Paid	-0.01	6.82	5.45	14	0.01	4.42	3.80	6.81	-0.04	0.85	0.63

This table presents Addus HomeCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Total Assets	1,413	1,024	938	948	893	637	348	272	230	186	181
Total Current Assets	260	200	223	324	288	269	176	156	131	94	97
Cash & Equivalents	99	65	80	169	145	112	70	54	8.01	4.10	13
Accounts Receivable	123	115	126	137	133	150	98	94	117	85	68
Prepaid Expenses	39	20	17	18	9.97	7.99	7.29	8.38	6.00	4.86	7.17
Plant, Property, & Equipment, net	25	24	21	18	20	12	11	7.49	6.65	8.62	7.70
Total Noncurrent Assets	1,128	800	694	605	585	355	161	109	92	83	76
Goodwill	971	663	583	504	469	275	135	90	73	69	64
Intangible Assets	110	92	72	64	72	57	24	17	15	10	10
Other Noncurrent Operating Assets	47	45	39	36	38	21	0.00	-	-	1.34	0.27
Total Liabilities & Shareholders' Equity	1,413	1,024	938	948	893	637	348	272	230	186	181
Total Liabilities	442	318	304	373	374	161	80	95	72	44	53
Total Current Liabilities	156	145	131	118	144	88	62	55	50	42	43
Short-Term Debt	0.00	0.00	0.00	0.00	0.97	0.73	0.06	3.10	2.53	1.11	0.99
Accounts Payable	27	26	22	19	24	20	12	7.38	4.49	4.75	3.95
Accrued Expenses	91	90	72	81	73	53	34	45	43	35	37
Current Employee Benefit Liabilities	14	12	13	13	14	14	15	-	-	-	-
Other Current Liabilities	24	17	24	4.17	32	0.00	-	-	-	1.25	1.00
Total Noncurrent Liabilities	286	173	173	256	230	74	18	40	22	1.88	9.64
Long-Term Debt	218	124	132	221	194	59	17	40	22	1.88	-
Noncurrent Deferred & Payable Income Tax Liabilities	26	8.53	0.00	0.00	-	-	-	-	-	-	5.85
Other Noncurrent Operating Liabilities	42	40	42	35	36	14	0.88	0.45	-	-	1.12
Total Equity & Noncontrolling Interests	970	707	634	574	519	476	268	176	158	142	128
Total Preferred & Common Equity	970	707	634	574	519	476	268	176	158	142	128
Total Common Equity	970	707	634	574	519	476	268	176	158	142	128
Common Stock	594	404	393	380	370	360	178	96	92	87	85
Retained Earnings	376	303	240	194	149	116	91	80	65	55	43

This table presents Addus HomeCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,408	1,153	1,117	1,014	1,036	928	931	946
Total Current Assets	258	333	295	192	211	208	209	240
Cash & Equivalents	97	223	173	77	80	84	74	106
Accounts Receivable	135	97	109	105	121	104	125	126
Prepaid Expenses	26	13	12	10	10	19	10	8.25
Plant, Property, & Equipment, net	25	24	23	24	21	20	20	17
Total Noncurrent Assets	1,125	796	798	798	804	701	702	688
Goodwill	972	664	664	663	663	584	584	575
Intangible Assets	108	87	88	90	94	69	71	73
Other Noncurrent Operating Assets	45	46	46	45	47	48	47	41
Total Liabilities & Shareholders' Equity	1,408	1,153	1,117	1,014	1,036	928	931	946
Total Liabilities	412	205	195	289	351	262	282	331
Total Current Liabilities	148	158	148	142	140	134	125	128
Accounts Payable	28	28	20	22	21	21	22	20
Accrued Expenses	85	92	91	83	87	80	68	75
Current Employee Benefit Liabilities	14	13	12	12	12	12	13	13
Other Current Liabilities	21	25	24	25	19	21	22	21
Total Noncurrent Liabilities	264	47	47	147	212	128	158	203
Long-Term Debt	199	0.00	0.00	99	164	79	108	164
Noncurrent Deferred & Payable Income Tax Liabilities	26	-	-	-	-	-	-	-
Other Noncurrent Operating Liabilities	40	47	47	48	48	49	49	39
Total Equity & Noncontrolling Interests	995	948	922	725	684	666	649	615
Total Preferred & Common Equity	995	948	922	725	684	666	649	615
Total Common Equity	995	948	922	725	684	666	649	615
Common Stock	598	591	585	406	401	399	396	389
Retained Earnings	398	357	337	319	283	268	253	226

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.06%	11.31%	10.02%	13.04%	17.88%	25.58%	21.28%	6.25%	19.04%	7.63%	17.67%
EBITDA Growth	10.69%	26.64%	2.98%	41.78%	24.44%	43.54%	-5.66%	49.87%	8.87%	-5.52%	24.00%
EBIT Growth	12.90%	32.32%	4.25%	48.15%	28.07%	52.24%	-10.38%	62.42%	-2.13%	-11.33%	16.88%
NOPAT Growth	8.80%	32.98%	6.73%	40.12%	30.02%	48.22%	28.90%	22.53%	-2.95%	-4.25%	7.86%
Net Income Growth	17.73%	35.83%	1.99%	36.20%	31.29%	53.58%	37.48%	-1.70%	4.62%	-5.06%	-36.05%
EPS Growth	10.44%	34.86%	1.07%	35.10%	17.51%	33.08%	29.13%	-3.74%	2.88%	-5.45%	-36.42%
Operating Cash Flow Growth	3.73%	6.79%	166.18%	-63.91%	810.32%	-63.80%	-37.08%	7,202.42%	-118.10%	-41.58%	-74.34%
Free Cash Flow Firm Growth	-2,202.93%	-67.87%	25.67%	92.12%	39.60%	-473.73%	-240.48%	199.57%	-116.14%	-38.77%	-132.72%
Invested Capital Growth	42.29%	11.77%	9.42%	10.18%	34.15%	96.76%	30.12%	-4.80%	24.44%	19.05%	20.50%
Revenue Q/Q Growth	1.83%	2.85%	2.41%	3.43%	0.48%	9.11%	5.29%	2.00%	5.01%	0.63%	4.25%
EBITDA Q/Q Growth	-1.12%	7.45%	1.27%	11.52%	-4.73%	29.41%	-3.33%	-2.73%	33.25%	-9.33%	12.06%
EBIT Q/Q Growth	-1.02%	8.54%	2.16%	13.11%	-5.95%	35.97%	-5.10%	-4.33%	48.55%	-12.20%	10.83%
NOPAT Q/Q Growth	-1.95%	7.37%	5.29%	11.51%	-5.45%	33.69%	16.43%	-24.63%	27.31%	-4.18%	4.33%
Net Income Q/Q Growth	-0.07%	8.35%	3.84%	11.38%	-6.46%	39.45%	13.95%	-33.86%	56.36%	-4.92%	33.00%
EPS Q/Q Growth	-2.98%	8.19%	2.90%	11.07%	-7.56%	33.08%	10.83%	-34.39%	55.07%	-4.59%	37.50%
Operating Cash Flow Q/Q Growth	-14.43%	5.41%	-0.86%	-21.65%	41.66%	-27.63%	-4.79%	386.64%	-102.82%	-50.07%	-28.87%
Free Cash Flow Firm Q/Q Growth	-304.39%	64.85%	-279.90%	95.29%	-53.98%	-271.42%	13.18%	244.23%	-2,727.78%	-992.96%	56.85%
Invested Capital Q/Q Growth	50.39%	-0.32%	1.87%	0.00%	42.50%	45.83%	-2.79%	-2.33%	28.71%	11.58%	4.94%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	32.48%	32.10%	31.51%	31.21%	29.58%	27.63%	26.48%	27.20%	24.68%	25.83%	26.76%
EBITDA Margin	10.16%	10.01%	8.80%	9.40%	7.49%	7.10%	6.21%	7.98%	5.66%	6.19%	7.05%
Operating Margin	8.89%	8.59%	7.23%	7.63%	5.82%	5.36%	4.42%	5.93%	3.86%	4.76%	5.77%
EBIT Margin	8.89%	8.59%	7.23%	7.63%	5.82%	5.36%	4.42%	5.98%	3.91%	4.76%	5.77%
Profit (Net Income) Margin	6.37%	5.91%	4.84%	5.22%	4.33%	3.89%	3.18%	2.81%	3.03%	3.45%	3.91%
Tax Burden Percent	74.08%	76.87%	76.49%	74.71%	79.00%	76.08%	80.54%	56.75%	75.24%	76.04%	70.40%
Interest Burden Percent	96.75%	89.41%	87.54%	91.60%	94.24%	95.45%	89.38%	82.70%	103.06%	95.39%	96.24%
Effective Tax Rate	25.92%	23.13%	23.51%	25.29%	21.00%	22.19%	20.08%	43.95%	25.36%	25.72%	31.21%
Return on Invested Capital (ROIC)	8.20%	9.63%	8.02%	8.25%	7.09%	8.46%	9.58%	8.34%	7.37%	9.26%	11.58%
ROIC Less NNEP Spread (ROIC-NNEP)	5.43%	-3.69%	-4.60%	0.12%	206.92%	11.90%	15.25%	-74.63%	16.01%	13.68%	12.96%
Return on Net Nonoperating Assets (RNNOA)	0.58%	-0.31%	-0.40%	0.01%	-0.42%	-1.68%	-2.19%	-1.19%	0.75%	-0.64%	-1.45%
Return on Equity (ROE)	8.78%	9.33%	7.62%	8.26%	6.66%	6.78%	7.39%	7.16%	8.12%	8.62%	10.13%
Cash Return on Invested Capital (CROIC)	-26.71%	-1.48%	-0.98%	-1.44%	-22.08%	-56.75%	-16.60%	13.26%	-14.41%	-8.13%	-7.02%
Operating Return on Assets (OROA)	8.43%	9.27%	7.29%	7.17%	5.82%	7.06%	7.37%	10.16%	7.55%	8.74%	10.48%
Return on Assets (ROA)	6.04%	6.37%	4.88%	4.90%	4.33%	5.13%	5.30%	4.77%	5.85%	6.34%	7.10%
Return on Common Equity (ROCE)	8.78%	9.33%	7.62%	8.26%	6.66%	6.78%	7.39%	7.16%	8.12%	8.62%	10.13%
Return on Equity Simple (ROE_SIMPLE)	7.58%	8.85%	7.26%	7.86%	6.39%	5.31%	6.12%	6.78%	7.71%	8.20%	9.57%
Net Operating Profit after Tax (NOPAT)	76	70	53	49	35	27	18	14	12	12	12
NOPAT Margin	6.59%	6.60%	5.53%	5.70%	4.60%	4.17%	3.53%	3.32%	2.88%	3.53%	3.97%
Net Nonoperating Expense Percent (NNEP)	2.76%	13.32%	12.62%	8.13%	-199.83%	-3.44%	-5.67%	82.97%	-8.65%	-4.42%	-1.39%
Return On Investment Capital (ROIC_SIMPLE)	6.40%	8.42%	6.87%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	67.52%	67.90%	68.49%	68.79%	70.42%	72.37%	73.52%	72.80%	75.32%	74.17%	73.24%
SG&A Expenses to Revenue	22.41%	22.18%	22.81%	21.91%	22.19%	20.64%	20.39%	18.05%	19.17%	19.64%	19.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.59%	23.51%	24.29%	23.59%	23.76%	22.27%	22.06%	21.27%	20.82%	21.08%	20.98%
Earnings before Interest and Taxes (EBIT)	103	91	69	66	45	35	23	25	16	16	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	117	106	84	81	57	46	32	34	23	21	22
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.34	2.13	2.53	2.59	3.57	3.18	3.31	2.30	2.55	1.82	2.08
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	264.50	0.00	10.57	8.14	5.83	5.76	4.14	5.00
Price to Revenue (P/Rev)	1.97	1.42	1.69	1.72	2.42	2.33	1.72	0.95	1.00	0.77	0.85
Price to Earnings (P/E)	30.88	24.08	34.83	33.00	55.87	59.94	54.11	33.86	33.04	22.25	21.79
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.24%	4.15%	2.87%	3.03%	1.79%	1.67%	1.85%	2.95%	3.03%	4.49%	4.59%
Enterprise Value to Invested Capital (EV/IC)	2.19	2.04	2.41	2.46	3.34	3.45	3.88	2.38	2.40	1.84	2.18
Enterprise Value to Revenue (EV/Rev)	2.07	1.48	1.74	1.78	2.49	2.25	1.62	0.92	1.04	0.76	0.82
Enterprise Value to EBITDA (EV/EBITDA)	20.40	14.77	19.78	18.97	33.18	31.73	26.06	11.59	18.42	12.31	11.61
Enterprise Value to EBIT (EV/EBIT)	23.30	17.20	24.07	23.38	42.71	42.04	36.62	15.47	26.65	16.01	14.17
Enterprise Value to NOPAT (EV/NOPAT)	31.45	22.38	31.47	31.29	54.06	54.02	45.82	27.84	36.18	21.56	20.60
Enterprise Value to Operating Cash Flow (EV/OCF)	20.55	13.94	15.74	39.03	17.37	121.55	25.18	7.47	0.00	62.49	36.44
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	17.51	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.23	0.18	0.21	0.38	0.38	0.13	0.06	0.24	0.16	0.02	0.03
Long-Term Debt to Equity	0.23	0.18	0.21	0.38	0.37	0.12	0.06	0.23	0.14	0.01	0.02
Financial Leverage	0.11	0.08	0.09	0.09	0.00	-0.14	-0.14	0.02	0.05	-0.05	-0.11
Leverage Ratio	1.45	1.46	1.56	1.68	1.54	1.32	1.39	1.50	1.39	1.36	1.43
Compound Leverage Factor	1.41	1.31	1.37	1.54	1.45	1.26	1.25	1.24	1.43	1.30	1.37
Debt to Total Capital	18.37%	14.94%	17.22%	27.78%	27.31%	11.18%	6.05%	19.59%	13.69%	2.07%	2.78%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.14%	0.14%	0.02%	1.41%	1.38%	0.77%	0.75%
Long-Term Debt to Total Capital	18.37%	14.94%	17.22%	27.78%	27.17%	11.05%	6.03%	18.18%	12.30%	1.30%	2.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	81.63%	85.06%	82.78%	72.22%	72.69%	88.82%	93.95%	80.41%	86.31%	97.93%	97.22%
Debt to EBITDA	1.86	1.17	1.58	2.72	3.40	1.30	0.54	1.26	1.10	0.14	0.17
Net Debt to EBITDA	1.02	0.56	0.62	0.64	0.87	-1.13	-1.66	-0.32	0.71	-0.10	-0.48
Long-Term Debt to EBITDA	1.86	1.17	1.58	2.72	3.38	1.29	0.54	1.17	0.99	0.09	0.12
Debt to NOPAT	2.87	1.78	2.51	4.48	5.54	2.21	0.95	3.04	2.17	0.25	0.29
Net Debt to NOPAT	1.57	0.85	0.99	1.06	1.42	-1.92	-2.91	-0.76	1.39	-0.17	-0.85
Long-Term Debt to NOPAT	2.87	1.78	2.51	4.48	5.51	2.19	0.94	2.82	1.95	0.16	0.22
Altman Z-Score	4.60	4.65	4.89	4.08	4.42	7.43	9.16	5.28	6.14	6.36	5.78
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.67	1.38	1.70	2.76	2.00	3.08	2.86	2.83	2.64	2.23	2.25
Quick Ratio	1.42	1.24	1.57	2.60	1.93	2.99	2.74	2.67	2.52	2.11	1.89
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-248	-11	-6.41	-8.63	-110	-181	-32	23	-23	-10	-7.53
Operating Cash Flow to CapEx	1,933.80%	1,189.18%	1,266.39%	850.12%	1,601.68%	260.10%	620.73%	0.00%	-43.40%	185.54%	133.26%
Free Cash Flow to Firm to Interest Expense	-32.06	-0.97	-0.72	-1.49	-34.35	-58.41	-6.30	5.03	-9.69	-13.30	-10.79
Operating Cash Flow to Interest Expense	15.06	10.11	11.80	6.80	34.31	3.87	6.62	11.80	-0.32	5.22	10.07
Operating Cash Flow Less CapEx to Interest Expense	14.28	9.26	10.87	6.00	32.17	2.38	5.55	11.82	-1.05	2.41	2.51
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	1.08	1.01	0.94	1.00	1.32	1.67	1.70	1.93	1.84	1.82
Accounts Receivable Turnover	9.69	8.79	7.25	6.41	5.42	5.23	5.39	4.05	3.97	4.39	4.83
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	47.40	46.85	47.96	45.22	47.94	56.88	56.94	60.27	52.52	41.29	60.59
Accounts Payable Turnover	29.22	29.78	31.43	27.62	24.85	29.46	38.72	52.27	65.40	57.43	53.40
Days Sales Outstanding (DSO)	37.68	41.55	50.36	56.91	67.37	69.76	67.77	90.19	91.93	83.06	75.63
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	12.49	12.26	11.61	13.22	14.69	12.39	9.43	6.98	5.58	6.36	6.83
Cash Conversion Cycle (CCC)	25.19	29.29	38.75	43.70	52.68	57.37	58.34	83.21	86.35	76.70	68.80
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,090	766	685	626	568	424	215	166	174	140	117
Invested Capital Turnover	1.24	1.46	1.45	1.45	1.54	2.03	2.71	2.51	2.56	2.62	2.91
Increase / (Decrease) in Invested Capital	324	81	59	58	145	208	50	-8.35	34	22	20
Enterprise Value (EV)	2,393	1,565	1,655	1,541	1,901	1,461	836	394	418	257	256
Market Capitalization	2,273	1,506	1,603	1,489	1,851	1,513	889	405	402	259	267
Book Value per Share	$53.52	$43.58	$39.33	$36.06	$32.81	$30.57	$20.50	$15.16	$13.76	$12.76	$11.64
Tangible Book Value per Share	($6.05)	($2.98)	($1.33)	$0.35	($1.39)	$9.20	$8.34	$5.96	$6.09	$5.63	$4.86
Total Capital	1,189	831	765	795	714	535	286	219	183	145	132
Total Debt	218	124	132	221	195	60	17	43	25	2.99	3.66
Total Long-Term Debt	218	124	132	221	194	59	17	40	22	1.88	2.68
Net Debt	120	59	52	52	50	-52	-53	-11	16	-2.01	-11
Capital Expenditures (CapEx)	6.02	9.44	8.30	4.65	6.83	4.62	5.35	-0.09	1.71	2.21	5.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	5.60	-9.90	12	38	-0.31	71	44	50	76	49	42
Debt-free Net Working Capital (DFNWC)	105	55	92	207	145	183	115	104	84	53	55
Net Working Capital (NWC)	105	55	92	207	144	182	115	101	81	52	54
Net Nonoperating Expense (NNE)	2.47	7.40	6.55	4.14	2.03	1.81	1.81	2.20	-0.61	0.28	0.19
Net Nonoperating Obligations (NNO)	120	59	52	52	50	-52	-53	-11	16	-2.01	-11
Total Depreciation and Amortization (D&A)	15	15	15	15	13	11	9.25	8.53	7.00	4.81	3.98
Debt-free, Cash-free Net Working Capital to Revenue	0.49%	-0.94%	1.23%	4.37%	-0.04%	10.92%	8.55%	11.72%	18.93%	14.47%	13.35%
Debt-free Net Working Capital to Revenue	9.05%	5.18%	9.64%	23.90%	18.93%	28.14%	22.18%	24.34%	20.93%	15.69%	17.62%
Net Working Capital to Revenue	9.05%	5.18%	9.64%	23.90%	18.80%	28.03%	22.16%	23.61%	20.30%	15.36%	17.31%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.33	$3.91	$2.90	$2.87	$2.12	$1.83	$1.45	$1.19	$1.06	$1.06	$1.12
Adjusted Weighted Average Basic Shares Outstanding	17.01M	16.00M	15.86M	15.74M	15.60M	13.82M	12.05M	11.47M	11.29M	10.99M	10.90M
Adjusted Diluted Earnings per Share	$4.23	$3.83	$2.84	$2.81	$2.08	$1.77	$1.41	$1.17	$1.06	$1.04	$1.10
Adjusted Weighted Average Diluted Shares Outstanding	17.38M	16.31M	16.18M	16.06M	15.96M	14.25M	12.38M	11.62M	11.35M	11.19M	11.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.17M	16.23M	16.13M	15.95M	15.83M	13.82M	13.18M	11.63M	11.53M	11.12M	11.01M
Normalized Net Operating Profit after Tax (NOPAT)	76	70	53	49	35	27	18	14	12	12	12
Normalized NOPAT Margin	6.59%	6.60%	5.53%	5.70%	4.60%	4.17%	3.53%	3.32%	2.88%	3.53%	3.97%
Pre Tax Income Margin	8.61%	7.68%	6.33%	6.99%	5.48%	5.11%	3.95%	4.94%	4.03%	4.54%	5.56%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.28	8.19	7.72	11.36	13.96	11.19	4.55	5.70	6.72	20.39	25.89
NOPAT to Interest Expense	9.84	6.30	5.90	8.49	11.03	8.71	3.64	3.17	4.95	15.14	17.81
EBIT Less CapEx to Interest Expense	12.50	7.34	6.79	10.56	11.81	9.70	3.48	5.71	5.99	17.57	18.33
NOPAT Less CapEx to Interest Expense	9.06	5.45	4.97	7.68	8.88	7.22	2.57	3.18	4.22	12.33	10.25
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Addus HomeCare's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.29%	7.52%	7.04%	10.36%	11.58%	11.86%	12.57%	9.72%	11.02%	9.98%	11.00%
EBITDA Growth	27.25%	-4.17%	11.02%	18.54%	22.72%	29.95%	25.99%	21.32%	29.11%	4.46%	0.88%
EBIT Growth	29.05%	-3.78%	13.63%	21.55%	27.07%	34.38%	30.39%	27.50%	37.70%	7.52%	0.90%
NOPAT Growth	36.60%	-7.19%	10.17%	17.56%	21.04%	28.48%	30.23%	29.62%	48.99%	18.53%	4.97%
Net Income Growth	34.10%	-0.27%	30.84%	21.73%	24.89%	32.62%	33.51%	32.02%	49.65%	13.05%	-0.29%
EPS Growth	19.59%	-10.92%	15.79%	20.88%	24.36%	32.22%	33.80%	30.00%	47.17%	9.76%	-1.39%
Operating Cash Flow Growth	-51.01%	-65.33%	122.75%	-54.79%	105.75%	23.70%	18.94%	-26.37%	214.21%	-3.61%	4.02%
Free Cash Flow Firm Growth	-601.66%	-414.41%	180.28%	-321.83%	-196.97%	-40.08%	-137.37%	148.64%	144.19%	3.50%	84.63%
Invested Capital Growth	46.73%	42.29%	-5.69%	13.24%	9.35%	11.77%	14.23%	-2.12%	-4.65%	9.42%	7.40%
Revenue Q/Q Growth	13.65%	2.54%	1.00%	2.20%	1.59%	2.08%	4.13%	3.33%	1.84%	2.73%	1.50%
EBITDA Q/Q Growth	13.90%	3.10%	-0.62%	9.03%	-14.23%	19.45%	6.12%	12.87%	-9.17%	15.80%	2.19%
EBIT Q/Q Growth	13.38%	3.70%	-0.87%	10.73%	-15.46%	22.47%	6.04%	15.75%	-10.60%	18.83%	3.68%
NOPAT Q/Q Growth	19.69%	4.53%	-0.57%	9.81%	-18.68%	24.08%	6.10%	13.05%	-13.68%	25.78%	5.60%
Net Income Q/Q Growth	8.72%	-3.16%	11.53%	14.21%	-19.14%	27.04%	3.76%	17.18%	-14.14%	27.89%	2.60%
EPS Q/Q Growth	9.43%	-3.64%	0.00%	13.40%	-18.49%	25.26%	4.40%	16.67%	-13.33%	26.76%	1.43%
Operating Cash Flow Q/Q Growth	81.89%	-78.53%	157.93%	-51.36%	28.72%	37.93%	-47.65%	121.36%	-22.61%	32.63%	-67.59%
Free Cash Flow Firm Q/Q Growth	-7.06%	-583.25%	192.23%	-47.05%	21.51%	24.58%	-354.84%	-35.72%	213.38%	-27.80%	47.78%
Invested Capital Q/Q Growth	0.66%	50.39%	-3.15%	0.08%	-2.38%	-0.32%	16.29%	-3.36%	-0.22%	1.87%	-0.36%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.88%	34.15%	31.82%	32.47%	31.41%	33.44%	32.04%	31.66%	31.17%	31.88%	31.26%
EBITDA Margin	10.30%	10.28%	10.22%	10.39%	9.73%	11.53%	9.85%	9.67%	8.85%	9.92%	8.80%
Operating Margin	9.04%	9.06%	8.96%	9.12%	8.42%	10.12%	8.44%	8.28%	7.40%	8.43%	7.28%
EBIT Margin	9.04%	9.06%	8.96%	9.12%	8.42%	10.12%	8.44%	8.28%	7.40%	8.43%	7.28%
Profit (Net Income) Margin	6.29%	6.57%	6.96%	6.30%	5.64%	7.08%	5.69%	5.71%	5.04%	5.98%	4.80%
Tax Burden Percent	78.63%	74.49%	73.89%	73.67%	74.28%	77.22%	76.22%	76.17%	77.99%	80.77%	76.31%
Interest Burden Percent	88.48%	97.41%	105.14%	93.74%	90.12%	90.65%	88.53%	90.53%	87.34%	87.81%	86.36%
Effective Tax Rate	21.37%	25.51%	26.11%	26.33%	25.72%	22.78%	23.78%	23.83%	22.01%	19.23%	23.69%
Return on Invested Capital (ROIC)	9.33%	8.39%	10.05%	10.63%	9.51%	11.40%	9.18%	9.44%	8.04%	9.87%	7.95%
ROIC Less NNEP Spread (ROIC-NNEP)	4.89%	7.81%	8.63%	11.99%	3.48%	7.77%	6.37%	4.99%	5.83%	5.92%	5.06%
Return on Net Nonoperating Assets (RNNOA)	0.35%	0.83%	-0.73%	-1.35%	0.15%	0.64%	0.70%	0.28%	0.79%	0.51%	0.54%
Return on Equity (ROE)	9.68%	9.23%	9.32%	9.29%	9.65%	12.05%	9.88%	9.71%	8.82%	10.38%	8.49%
Cash Return on Invested Capital (CROIC)	-28.94%	-26.71%	16.25%	-1.65%	1.26%	-1.48%	-4.25%	11.29%	12.94%	-0.98%	0.55%
Operating Return on Assets (OROA)	9.04%	8.58%	9.28%	9.95%	9.42%	10.92%	8.76%	8.75%	7.53%	8.50%	7.23%
Return on Assets (ROA)	6.29%	6.23%	7.21%	6.87%	6.31%	7.64%	5.91%	6.03%	5.13%	6.03%	4.77%
Return on Common Equity (ROCE)	9.68%	9.23%	9.32%	9.29%	9.65%	12.05%	9.88%	9.71%	8.82%	10.38%	8.49%
Return on Equity Simple (ROE_SIMPLE)	7.94%	0.00%	7.77%	7.48%	9.06%	0.00%	8.43%	8.08%	7.74%	0.00%	7.21%
Net Operating Profit after Tax (NOPAT)	24	20	19	19	18	22	17	16	15	17	13
NOPAT Margin	7.10%	6.75%	6.62%	6.72%	6.26%	7.82%	6.43%	6.31%	5.77%	6.80%	5.56%
Net Nonoperating Expense Percent (NNEP)	4.44%	0.58%	1.42%	-1.35%	6.03%	3.63%	2.81%	4.44%	2.21%	3.95%	2.89%
Return On Investment Capital (ROIC_SIMPLE)	2.01%	1.69%	-	-	-	2.60%	-	-	-	2.20%	-
Cost of Revenue to Revenue	68.12%	65.85%	68.18%	67.53%	68.59%	66.56%	67.96%	68.34%	68.83%	68.12%	68.74%
SG&A Expenses to Revenue	21.68%	24.01%	21.67%	22.16%	21.75%	21.99%	22.26%	22.08%	22.40%	22.05%	22.55%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	22.85%	25.10%	22.86%	23.34%	22.99%	23.32%	23.60%	23.38%	23.77%	23.46%	23.98%
Earnings before Interest and Taxes (EBIT)	31	27	26	26	24	28	23	22	19	21	18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	35	31	30	30	27	32	27	25	22	25	21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.81	2.34	2.54	2.06	2.31	2.13	2.02	2.25	2.65	2.53	2.49
Price to Tangible Book Value (P/TBV)	0.00	0.00	12.20	11.22	0.00	0.00	0.00	108.57	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.48	1.97	2.12	1.71	1.54	1.42	1.34	1.50	1.76	1.69	1.65
Price to Earnings (P/E)	22.75	30.88	32.69	27.59	25.52	24.08	23.94	27.90	34.28	34.83	34.55
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	4.40%	3.24%	3.06%	3.62%	3.92%	4.15%	4.18%	3.58%	2.92%	2.87%	2.89%
Enterprise Value to Invested Capital (EV/IC)	1.73	2.19	3.01	2.31	2.27	2.04	1.91	2.26	2.57	2.41	2.36
Enterprise Value to Revenue (EV/Rev)	1.57	2.07	1.93	1.55	1.56	1.48	1.42	1.50	1.80	1.74	1.71
Enterprise Value to EBITDA (EV/EBITDA)	15.23	20.40	18.42	14.94	15.30	14.77	14.86	16.08	19.81	19.78	19.24
Enterprise Value to EBIT (EV/EBIT)	17.33	23.30	21.06	17.17	17.69	17.20	17.49	19.07	23.79	24.07	23.62
Enterprise Value to NOPAT (EV/NOPAT)	23.05	31.45	28.16	22.78	23.27	22.38	22.50	24.50	30.64	31.47	31.83
Enterprise Value to Operating Cash Flow (EV/OCF)	19.64	20.55	16.06	15.80	12.85	13.94	13.76	14.53	14.90	15.74	14.99
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	18.01	0.00	187.95	0.00	0.00	19.84	19.38	0.00	445.87
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.23	0.00	0.00	0.14	0.18	0.24	0.12	0.17	0.21	0.27
Long-Term Debt to Equity	0.20	0.23	0.00	0.00	0.14	0.18	0.24	0.12	0.17	0.21	0.27
Financial Leverage	0.07	0.11	-0.09	-0.11	0.04	0.08	0.11	0.06	0.13	0.09	0.11
Leverage Ratio	1.41	1.45	1.34	1.29	1.42	1.46	1.53	1.50	1.55	1.56	1.60
Compound Leverage Factor	1.25	1.42	1.41	1.21	1.28	1.33	1.35	1.35	1.36	1.37	1.38
Debt to Total Capital	16.64%	18.37%	0.00%	0.00%	12.05%	14.94%	19.32%	10.56%	14.32%	17.22%	21.01%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	16.64%	18.37%	0.00%	0.00%	12.05%	14.94%	19.32%	10.56%	14.32%	17.22%	21.01%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	83.36%	81.63%	100.00%	100.00%	87.95%	85.06%	80.68%	89.44%	85.68%	82.78%	78.99%
Debt to EBITDA	1.59	1.86	0.00	0.00	0.90	1.17	1.66	0.85	1.22	1.58	1.98
Net Debt to EBITDA	0.82	1.02	0.00	0.00	0.20	0.56	0.85	-0.06	0.39	0.62	0.70
Long-Term Debt to EBITDA	1.59	1.86	0.00	0.00	0.90	1.17	1.66	0.85	1.22	1.58	1.98
Debt to NOPAT	2.41	2.87	0.00	0.00	1.36	1.78	2.52	1.29	1.89	2.51	3.28
Net Debt to NOPAT	1.24	1.57	0.00	0.00	0.31	0.85	1.29	-0.09	0.61	0.99	1.16
Long-Term Debt to NOPAT	2.41	2.87	0.00	0.00	1.36	1.78	2.52	1.29	1.89	2.51	3.28
Altman Z-Score	4.04	4.43	8.71	7.51	5.13	4.44	3.89	5.09	5.26	4.72	4.29
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.74	1.67	2.11	2.00	1.35	1.38	1.51	1.55	1.68	1.70	1.87
Quick Ratio	1.57	1.42	2.02	1.91	1.28	1.24	1.44	1.41	1.60	1.57	1.81
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-325	-304	63	-68	-46	-59	-78	31	48	-42	-33
Operating Cash Flow to CapEx	1,010.07%	613.91%	2,524.71%	1,756.58%	2,865.04%	566.43%	921.92%	4,186.52%	2,419.43%	446.87%	1,381.30%
Free Cash Flow to Firm to Interest Expense	-80.99	-132.90	109.77	-32.26	-16.82	-18.97	-24.49	13.19	19.43	-16.04	-13.35
Operating Cash Flow to Interest Expense	4.72	4.56	84.69	8.90	14.02	9.65	6.81	17.85	7.64	9.24	7.41
Operating Cash Flow Less CapEx to Interest Expense	4.25	3.81	81.33	8.39	13.53	7.94	6.07	17.43	7.32	7.17	6.87
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.00	0.95	1.04	1.09	1.12	1.08	1.04	1.06	1.02	1.01	0.99
Accounts Receivable Turnover	10.12	9.69	10.42	10.45	9.45	8.79	8.32	8.73	7.44	7.25	7.14
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	49.89	47.40	51.27	51.86	49.31	46.85	54.26	53.52	49.65	47.96	51.53
Accounts Payable Turnover	32.69	29.22	31.28	36.90	33.72	29.78	34.37	32.56	31.25	31.43	29.73
Days Sales Outstanding (DSO)	36.05	37.68	35.04	34.94	38.62	41.55	43.86	41.79	49.03	50.36	51.11
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.17	12.49	11.67	9.89	10.82	12.26	10.62	11.21	11.68	11.61	12.28
Cash Conversion Cycle (CCC)	24.89	25.19	23.37	25.05	27.79	29.29	33.24	30.58	37.35	38.75	38.83
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,097	1,090	725	748	748	766	769	661	684	685	673
Invested Capital Turnover	1.31	1.24	1.52	1.58	1.52	1.46	1.43	1.50	1.39	1.45	1.43
Increase / (Decrease) in Invested Capital	349	324	-44	87	64	81	96	-14	-33	59	46
Enterprise Value (EV)	1,899	2,393	2,185	1,727	1,698	1,565	1,465	1,497	1,757	1,655	1,589
Market Capitalization	1,797	2,273	2,408	1,901	1,676	1,506	1,381	1,502	1,722	1,603	1,531
Book Value per Share	$54.77	$53.52	$52.35	$56.30	$45.14	$43.58	$42.20	$41.12	$40.23	$39.33	$38.24
Tangible Book Value per Share	($4.66)	($6.05)	$10.91	$10.35	($1.77)	($2.98)	($4.47)	$0.85	($0.35)	($1.33)	($2.05)
Total Capital	1,194	1,189	948	922	824	831	848	745	757	765	778
Total Debt	199	218	0.00	0.00	99	124	164	79	108	132	164
Total Long-Term Debt	199	218	0.00	0.00	99	124	164	79	108	132	164
Net Debt	102	120	-223	-173	23	59	84	-5.49	35	52	58
Capital Expenditures (CapEx)	1.88	1.70	1.92	1.07	1.35	5.31	2.36	0.99	0.78	5.44	1.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	13	5.60	-48	-26	-26	-9.90	-8.14	-10	11	12	6.31
Debt-free Net Working Capital (DFNWC)	110	105	175	147	50	55	72	74	85	92	112
Net Working Capital (NWC)	110	105	175	147	50	55	72	74	85	92	112
Net Nonoperating Expense (NNE)	2.76	0.52	-0.99	1.21	1.73	2.02	2.00	1.55	1.84	2.05	1.82
Net Nonoperating Obligations (NNO)	102	120	-223	-173	23	59	84	-5.49	35	52	58
Total Depreciation and Amortization (D&A)	4.26	3.62	3.66	3.62	3.68	3.89	3.84	3.60	3.66	3.70	3.66
Debt-free, Cash-free Net Working Capital to Revenue	1.07%	0.49%	-4.22%	-2.32%	-2.43%	-0.94%	-0.79%	-1.03%	1.13%	1.23%	0.68%
Debt-free Net Working Capital to Revenue	9.07%	9.05%	15.43%	13.23%	4.62%	5.18%	6.96%	7.40%	8.66%	9.64%	12.05%
Net Working Capital to Revenue	9.07%	9.05%	15.43%	13.23%	4.62%	5.18%	6.96%	7.40%	8.66%	9.64%	12.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.18	$1.09	$1.13	$1.12	$0.99	$1.23	$0.96	$0.93	$0.79	$0.92	$0.73
Adjusted Weighted Average Basic Shares Outstanding	17.98M	17.01M	17.87M	16.18M	16.06M	16.00M	16.01M	16.00M	15.95M	15.86M	15.87M
Adjusted Diluted Earnings per Share	$1.16	$1.06	$1.10	$1.10	$0.97	$1.19	$0.95	$0.91	$0.78	$0.90	$0.71
Adjusted Weighted Average Diluted Shares Outstanding	18.31M	17.38M	18.26M	16.50M	16.37M	16.31M	16.29M	16.28M	16.30M	16.18M	16.18M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	18.40M	18.17M	18.13M	18.10M	16.37M	16.23M	16.21M	16.21M	16.20M	16.13M	16.11M
Normalized Net Operating Profit after Tax (NOPAT)	24	20	19	19	18	22	17	16	15	17	13
Normalized NOPAT Margin	7.10%	6.75%	6.62%	6.72%	6.26%	7.82%	6.43%	6.31%	5.77%	6.80%	5.56%
Pre Tax Income Margin	7.99%	8.82%	9.42%	8.55%	7.59%	9.17%	7.47%	7.50%	6.46%	7.40%	6.29%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.59	11.77	45.29	12.38	8.57	8.98	7.14	9.24	7.56	7.92	7.09
NOPAT to Interest Expense	5.97	8.77	33.47	9.12	6.37	6.93	5.44	7.04	5.90	6.39	5.41
EBIT Less CapEx to Interest Expense	7.13	11.03	41.94	11.88	8.08	7.28	6.40	8.81	7.25	5.85	6.55
NOPAT Less CapEx to Interest Expense	5.50	8.02	30.11	8.62	5.88	5.23	4.70	6.61	5.58	4.33	4.87
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Addus HomeCare's Financials

When does Addus HomeCare's fiscal year end?

According to the most recent income statement we have on file, Addus HomeCare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Addus HomeCare's net income changed over the last 10 years?

Addus HomeCare's net income appears to be on an upward trend, with a most recent value of $73.60 million in 2024, rising from $12.24 million in 2014. The previous period was $62.52 million in 2023. Find out what analysts predict for Addus HomeCare in the coming months.

What is Addus HomeCare's operating income?

Addus HomeCare's total operating income in 2024 was $102.69 million, based on the following breakdown:

Total Gross Profit: $375.02 million
Total Operating Expenses: $272.33 million

How has Addus HomeCare revenue changed over the last 10 years?

Over the last 10 years, Addus HomeCare's total revenue changed from $312.94 million in 2014 to $1.15 billion in 2024, a change of 268.9%.

How much debt does Addus HomeCare have?

Addus HomeCare's total liabilities were at $442.14 million at the end of 2024, a 39.2% increase from 2023, and a 736.6% increase since 2014.

How much cash does Addus HomeCare have?

In the past 10 years, Addus HomeCare's cash and equivalents has ranged from $4.10 million in 2015 to $168.90 million in 2021, and is currently $98.91 million as of their latest financial filing in 2024.

How has Addus HomeCare's book value per share changed over the last 10 years?

Over the last 10 years, Addus HomeCare's book value per share changed from 11.64 in 2014 to 53.52 in 2024, a change of 359.7%.

Related Companies

This page (NASDAQ:ADUS) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Financials

Frequently Asked Questions About Addus HomeCare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Financials

Annual Income Statements for Addus HomeCare

Quarterly Income Statements for Addus HomeCare

Annual Cash Flow Statements for Addus HomeCare

Quarterly Cash Flow Statements for Addus HomeCare

Annual Balance Sheets for Addus HomeCare

Quarterly Balance Sheets for Addus HomeCare

Annual Metrics And Ratios for Addus HomeCare

Quarterly Metrics And Ratios for Addus HomeCare

Frequently Asked Questions About Addus HomeCare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools